(Q38130105)

29 August 2017

title

Lobular breast cancer: pathology, biology, and options for clinical intervention (English)

1 reference

29 August 2017

4

Paul J van Diest

1 reference

29 August 2017

Eva Vlug

1

1 reference

29 August 2017

Cigdem Ercan

series ordinal

2

1 reference

29 August 2017

Elsken van der Wall

series ordinal

3

1 reference

29 August 2017

Patrick W B Derksen

series ordinal

5

1 reference

29 August 2017

publication date

1 February 2014

1 reference

Archivum Immunologiae et Therapiae Experimentalis

29 August 2017

published in

1 reference

29 August 2017

volume

62

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

7-21

1 reference

High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

An 81-year-old patient with distant metastasis of invasive lobular carcinoma occurring 41 years after mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The management of lobular neoplasia identified on percutaneous core breast biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Mutations of the human E-cadherin (CDH1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

PTEN, more than the AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Lobular neoplasia. Long term risk of breast cancer and relation to other factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Is pleomorphic lobular carcinoma really a distinct clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Oncogenic PIK3CA mutations in lobular breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

A core function for p120-catenin in cadherin turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Histologic variants of infiltrating lobular carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Lobular neoplasia (so-called lobular carcinoma in situ) of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The cytoskeleton and classical cadherin adhesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Competitive regulation of E-cadherin juxtamembrane domain degradation by p120-catenin binding and Hakai-mediated ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Vinculin is associated with the E-cadherin adhesion complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Receptor conversion in distant breast cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Spontaneous assembly and active disassembly balance adherens junction homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Invasive lobular breast cancer: subtypes and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Tumor hypoxia: a target for selective cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Recycling of E-cadherin: a potential mechanism for regulating cadherin dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Development of personalized tumor biomarkers using massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Clinical management issues in percutaneous core breast biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Dynein binds to beta-catenin and may tether microtubules at adherens junctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The secret life of α-catenin: moonlighting in morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Germline E-cadherin mutations in familial lobular breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Anchorage of microtubule minus ends to adherens junctions regulates epithelial cell-cell contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

A dileucine motif in its cytoplasmic domain directs beta-catenin-uncoupled E-cadherin to the lysosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The life history of 21 breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Genetic alterations in lobular breast cancer by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Historical and epidemiologic background of human premalignant breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Lobular carcinoma in situ of the breast: mammographic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Centralspindlin and α-catenin regulate Rho signalling at the epithelial zonula adherens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Quantifying the value of in-house consultation in surgical pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The significance of malignancies incidental to microcalcifications in breast spot localization biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Keratin expression in breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

p53 alterations in human cancer: more questions than answers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

α-Catenin contributes to the strength of E-cadherin-p120 interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Bilaterality of cancer of the breast. Biopsy of the opposite breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Columnar cell lesions on breast needle biopsies: is surgical excision necessary? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Pleomorphic variant of invasive lobular carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

The genomic landscapes of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Deconstructing the cadherin-catenin-actin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

A novel interaction between kinesin and p120 modulates p120 localization and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Clinicopathologic characteristics of invasive lobular carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Epigenetic and genetic alterations ofAPCandCDH1genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

Lobular carcinoma in situ: mammographic-pathologic correlation of results of needle-directed biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0251-0

10.1007/S00005-013-0251-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1026700248

0 references

1 reference